Generation of a CRISPR/Cas9-corrected isogenic control iPSC line (NIMHi001-A-1) from a Parkinson's disease Patient-Derived iPSC line carrying the LRRK2 I1371V mutation.
We report NIMHi001-A-1, a CRISPR/Cas9-corrected isogenic iPSC line derived from a patient line carrying a heterozygous LRRK2 missense mutation GRCh38 chr12:g.40308618A > G [(MANE transcript NM_198578.4:c.4111A > G); p.Ile1371Val] associated with familial Parkinson's disease. Sanger sequencing confirmed successful corre...